Delving into the Latest Updates on G.C. Chemie Pharmie Ltd. with Synapse

概览

关联

7

项与 G.C. Chemie Pharmie Ltd. 相关的临床试验

CTRI/2025/09/094225

/ Not yet recruitingN/A

A double blind, balanced, randomized, two-treatment, two-sequence, two-period, single dose, crossover, pharmacokinetic and pharmacodynamic bioequivalence study of insulin degludec and insulin aspart injection 100 units/mL of G. C Chemie Pharmie Limited, India comparing with Ryzodeg (Insulin degludec/Insulin aspart) 100 units/mL of Novo Nordisk A/S, Novo All?, DK-2880 Bagsv?rd, Denmark, in healthy, adult, human male subjects using Euglycemic clamp technique under fasting conditions.

开始日期2025-10-06

申办/合作机构

G.C. Chemie Pharmie Ltd.

CTRI/2022/12/047860

/ Not yet recruiting临床3期

A prospective, randomized, open-label, active-controlled, clinical study to evaluate the tolerability and incidence of pregnancy complications up on Lipocal supplementation in pregnant women

开始日期2022-12-05

申办/合作机构

G.C. Chemie Pharmie Ltd.

CTRI/2022/11/047443

/ Active, not recruiting临床3期

A Randomized, Double-Blind, Multi-center, Phase III Study to Assess and Compare the Immunogenicity and Safety of the 13-valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13-TT) with PREVENAR 13® of Pfizer Inc. in Healthy Infants in India

开始日期2022-11-21

申办/合作机构

G.C. Chemie Pharmie Ltd.

100 项与 G.C. Chemie Pharmie Ltd. 相关的临床结果

登录后查看更多信息

0 项与 G.C. Chemie Pharmie Ltd. 相关的专利（医药）

登录后查看更多信息

100 项与 G.C. Chemie Pharmie Ltd. 相关的药物交易

登录后查看更多信息

100 项与 G.C. Chemie Pharmie Ltd. 相关的转化医学

登录后查看更多信息